MeiraGTx (MGTX) News Today $6.43 +0.21 (+3.38%) Closing price 04:00 PM EasternExtended Trading$6.43 0.00 (0.00%) As of 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period MeiraGTx Holdings plc's (NASDAQ:MGTX) top owners are private equity firms with 25% stake, while 21% is held by institutionsJanuary 30 at 11:43 AM | finance.yahoo.comCritical Analysis: MeiraGTx (NASDAQ:MGTX) & Immunocore (NASDAQ:IMCR)January 26, 2025 | americanbankingnews.comMeiraGTx's AAV8-RK-RetGC Program Gets FDA's Rare Pediatric Disease DesignationJanuary 22, 2025 | markets.businessinsider.comMeiraGTx receives RPDD from FDA for AAV8-RK-RetGC programJanuary 22, 2025 | markets.businessinsider.comMeiraGTx: 2 Possible Near-Term BLA Filings Could Ignite Shareholder ValueJanuary 22, 2025 | seekingalpha.comMeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D MutationsJanuary 22, 2025 | globenewswire.comRichard Giroux Sells 24,000 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) StockJanuary 22, 2025 | insidertrades.comMeiraGTX CFO Richard Giroux sells $150,960 in ordinary sharesJanuary 21, 2025 | msn.comMeiraGTx Holdings plc (NASDAQ:MGTX) CFO Richard Giroux Sells 24,000 SharesMeiraGTx Holdings plc (NASDAQ:MGTX - Get Free Report) CFO Richard Giroux sold 24,000 shares of the company's stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $6.29, for a total value of $150,960.00. Following the transaction, the chief financial officer now owns 849,947 shares of the company's stock, valued at approximately $5,346,166.63. This trade represents a 2.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.January 21, 2025 | marketbeat.comIs MeiraGTx Holdings plc (MGTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?January 20, 2025 | insidermonkey.comMeiraGTx (NASDAQ:MGTX) Stock Price Up 8% - Time to Buy?MeiraGTx (NASDAQ:MGTX) Trading 8% Higher - Should You Buy?January 17, 2025 | marketbeat.comBarclays PLC Acquires 76,437 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX)Barclays PLC increased its holdings in MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) by 107.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 147,827 shares of the company's stock after buying an addJanuary 17, 2025 | marketbeat.comInsider Selling: MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Sells 35,839 Shares of StockJanuary 11, 2025 | insidertrades.comMeiraGTx Holdings plc (NASDAQ:MGTX) CEO Sells $231,878.33 in StockMeiraGTx Holdings plc (NASDAQ:MGTX - Get Free Report) CEO Alexandria Forbes sold 35,839 shares of the firm's stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $6.47, for a total value of $231,878.33. Following the completion of the transaction, the chief executive officer now owns 1,395,102 shares of the company's stock, valued at approximately $9,026,309.94. This represents a 2.50 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.January 10, 2025 | marketbeat.comMeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now?December 29, 2024 | msn.comMeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now?December 29, 2024 | insidermonkey.comMeiraGTx (NASDAQ:MGTX) Trading Up 10.1% - What's Next?MeiraGTx (NASDAQ:MGTX) Stock Price Up 10.1% - Still a Buy?December 20, 2024 | marketbeat.com392,400 Shares in MeiraGTx Holdings plc (NASDAQ:MGTX) Purchased by Garden State Investment Advisory Services LLCGarden State Investment Advisory Services LLC bought a new position in shares of MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 392,400 shares of the company'December 13, 2024 | marketbeat.comInvestors in MeiraGTx Holdings (NASDAQ:MGTX) have unfortunately lost 71% over the last five yearsDecember 13, 2024 | uk.finance.yahoo.comMeiraGTx granted RMAT designation by U.S. FDA to AAV2-hAQP1December 11, 2024 | finance.yahoo.comMeiraGTx Says FDA Grants RMAT Designation For AAV2-hAQP1 To Treat Radiation-Induced XerostomiaDecember 9, 2024 | markets.businessinsider.comMeiraGTx Holdings: Behind The Recent RallyDecember 3, 2024 | seekingalpha.comErste Asset Management GmbH Buys Shares of 669,702 MeiraGTx Holdings plc (NASDAQ:MGTX)Erste Asset Management GmbH bought a new position in MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 669,702 shares of the company's stock, valued at approximaDecember 3, 2024 | marketbeat.comMeiraGTx (NASDAQ:MGTX) Shares Gap Up - What's Next?MeiraGTx (NASDAQ:MGTX) Shares Gap Up - What's Next?November 29, 2024 | marketbeat.comKnoll Capital Management LLC Invests $5.21 Million in MeiraGTx Holdings plc (NASDAQ:MGTX)Knoll Capital Management LLC acquired a new stake in shares of MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,250,000 shares of the company's stock, valued at apprNovember 29, 2024 | marketbeat.comMeiraGTx Holdings Reports Significant Losses Amid Strategic MovesNovember 15, 2024 | markets.businessinsider.comMeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To KnowNovember 15, 2024 | finance.yahoo.comMeiraGTx reports Q3 EPS (55c) vs (74c) last yearNovember 14, 2024 | markets.businessinsider.comRBC Capital Sticks to Its Buy Rating for Meiragtx Holdings (MGTX)November 14, 2024 | markets.businessinsider.comMeiraGTx announecs five posters at ESGCT 2024 Annual CongressOctober 22, 2024 | markets.businessinsider.comMeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual CongressOctober 22, 2024 | markets.businessinsider.comMeiraGTx Holdings: Promising Growth Potential with Strategic Manufacturing and Positive Clinical ResultsOctober 17, 2024 | markets.businessinsider.comMeiraGTx Holdings Reports Promising Parkinson’s Therapy ResultsOctober 16, 2024 | finance.yahoo.comMeiraGTx Shares Rise on Positive Data for Parkinson's Disease TreatmentOctober 15, 2024 | marketwatch.comMeiraGTx Reports Positive AAV-GAD Trial Data For Parkinson's Disease; Stock ClimbsOctober 15, 2024 | markets.businessinsider.comSmall Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy EndpointsOctober 15, 2024 | finance.yahoo.comMeiraGTx gains as gene therapy shows promise in Parkinson’sOctober 15, 2024 | msn.comMeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience ConferenceOctober 9, 2024 | globenewswire.comMeiraGTx Holdings plc's (NASDAQ:MGTX) Profit OutlookOctober 7, 2024 | finance.yahoo.comSensorion SA (RFM.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comIs MeiraGTx Holdings plc (MGTX) The Best Rated Penny Stock To Buy According to Analysts?August 30, 2024 | msn.comPerceptive advisors buys $5 million in MeiraGTx holdings sharesAugust 17, 2024 | uk.investing.comMeiraGTx shares target price cut by RBC Capital on clinical updatesAugust 15, 2024 | uk.investing.comInsider Buying: MeiraGTx Holdings plc (NASDAQ:MGTX) Director Purchases 1,250,000 Shares of StockAugust 15, 2024 | insidertrades.comMeiraGTx Holdings plc (NASDAQ:MGTX) Director Perceptive Advisors Llc Buys 1,250,000 SharesMeiraGTx Holdings plc (NASDAQ:MGTX - Get Free Report) Director Perceptive Advisors Llc bought 1,250,000 shares of the stock in a transaction dated Monday, August 12th. The stock was purchased at an average cost of $4.00 per share, with a total value of $5,000,000.00. Following the completion of the purchase, the director now directly owns 12,531,103 shares in the company, valued at approximately $50,124,412. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.August 14, 2024 | marketbeat.comMeiraGTx (NASDAQ:MGTX) Announces Quarterly Earnings Results, Misses Estimates By $0.45 EPSMeiraGTx (NASDAQ:MGTX - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.76) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.45). MeiraGTx had a negative return on equity of 122.82% and a negative net margin of 651.19%. The business had revenue of $0.28 million during the quarter, compared to analyst estimates of $16.38 million.August 14, 2024 | marketbeat.comRoyal Bank of Canada Cuts MeiraGTx (NASDAQ:MGTX) Price Target to $9.00Royal Bank of Canada lowered their price objective on MeiraGTx from $11.00 to $9.00 and set an "outperform" rating on the stock in a research report on Tuesday.August 13, 2024 | marketbeat.comMeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational ResultsAugust 12, 2024 | globenewswire.comMeiraGTx Announces Pricing of Offering of Ordinary Shares Led by SanofiAugust 12, 2024 | globenewswire.comMeiraGTx Holdings plc's (NASDAQ:MGTX) top owners are private equity firms with 28% stake, while 21% is held by individual investorsAugust 5, 2024 | finance.yahoo.com Get MeiraGTx News Delivered to You Automatically Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address MGTX Media Mentions By Week MGTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGTX News Sentiment▼0.610.74▲Average Medical News Sentiment MGTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGTX Articles This Week▼31▲MGTX Articles Average Week Get MeiraGTx News Delivered to You Automatically Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGIO News Today IOVA News Today WVE News Today APGE News Today AMPH News Today BLTE News Today SDGR News Today ARQT News Today IRON News Today INDV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGTX) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
